Panel discussion


Date:April 23, 2024

Panel title

Pioneering Partnerships: Biotech alliances to patient impact

Panel summary

The CSL theme at SBA 2024 encapsulates the event’s focus on fostering strategic alliances across the biotech landscape. Featuring distinguished panellists including Amanda Gett-Chaperot, Eve Williamson, Maria Crespo, and Emmanuelle Lecomte Brisset, we will delve into the nuances of venture creation, innovation scouting, and the development pathways that lead from early-stage research to market-ready solutions.

Speaker information


Adrian Zuercher, Vice President, Research EU & Head Plasma Protein Research, CSL


Amanda Gett- Chaperot, Partner, Kurma Partners
Eve Williamson, Vice President, Global Head of Business Development, CSL
Maria Crespo, Director, Bioprocess Development, CSL
Emmanuelle Lecomte Brisset, Senior Vice President, Head Global Regulatory Affairs, CSL

Company profile

CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.

Follow us